| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 11/24/2010 | EP2253321A1 Collyrium for the treatment of conial cornea with "cross-linking" trans-epithelial technique |
| 11/24/2010 | EP2252690A2 Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars |
| 11/24/2010 | EP2252285A1 Abnormal intraocular pressure treatment |
| 11/24/2010 | EP2252276A1 Methods for the treatment and prevention of age-related retinal dysfunction |
| 11/24/2010 | EP1940353B1 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 11/24/2010 | EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/24/2010 | EP1539739B1 Piperidinyl compounds that selectively bind integrins |
| 11/24/2010 | EP1502949B1 Antimicrobial polypeptide and utilization thereof |
| 11/24/2010 | CN101891738A Dasatinib polymorph and preparation method and medical composite thereof |
| 11/24/2010 | CN101891680A Modulators of atp-binding cassette transporters |
| 11/24/2010 | CN101890167A Conveniently implantable sustained release drug compositions |
| 11/24/2010 | CN101890166A Combination of organic compounds |
| 11/24/2010 | CN101890163A Use of anti-tnfalpha antibodies and another drug |
| 11/24/2010 | CN101890116A Anthocyanin health-care eye drops and preparation method thereof |
| 11/24/2010 | CN101890071A Method for identifying Gentiana rigescens Franch and Gentiana manshurica Kitag medicinal materials |
| 11/24/2010 | CN101889976A Acyclovir injection and preparation method thereof |
| 11/24/2010 | CN101139393B KDR peptides and vaccines containing the same |
| 11/24/2010 | CN101121706B Coumarin derivatives, preparation method and use thereof |
| 11/24/2010 | CN101011569B Method for diagnosing and treating type II dentinogenesis by using DSPP gene and encoding product thereof |
| 11/23/2010 | US7838644 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field |
| 11/23/2010 | US7838565 Suppresses reduction in peripheral nerve conduction rate and alleviates hypofunction of bladder so that it is useful as a preventive and/or therapeutic agent for, particularly, diabetic neuropathy |
| 11/23/2010 | US7838557 treating an allergic reaction by topically administering a therapeutically effective amount of an X-ray contrast medium comprising a triiodinated benzene moiety that is completely or partially substituted, and where contrast medium is a non-ionic or ionic monomer, a non-ionic or ionic dimer |
| 11/23/2010 | US7838541 Methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes. |
| 11/23/2010 | US7838290 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 11/23/2010 | US7838289 Assay utilizing multipotent adult stem cells |
| 11/23/2010 | US7838043 administering scavenger of superoxide anion or nitric oxide comprising fine powder of platinum (colloid) which is prepared by metal salt reduction in presence of water-soluble polymer comprising polyvinylpyrrolidone, polyvinyl alcohol, polyacrylic acid, cyclodextrin, amylopectin, and methylcellulose |
| 11/23/2010 | US7836883 Methods for treating rhinitis and conjunctivitis |
| 11/18/2010 | WO2010130462A2 Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 11/18/2010 | WO2010130418A2 Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor |
| 11/18/2010 | WO2010081091A3 Therapeutic compositions for treatment of corneal disorders |
| 11/18/2010 | US20100292314 Anti-angiogenic compositions and methods of use |
| 11/18/2010 | US20100292305 RNAi MODULATION OF HIF-1 AND THERAPUTIC USES THEREOF |
| 11/18/2010 | US20100292293 Therapeutic substituted lactams |
| 11/18/2010 | US20100292272 Supramolecular co-colloids produced using macrocyclic polyanionic systems |
| 11/18/2010 | US20100292254 Fused Pyrimidine Derivatives as Trpv3 Modulators |
| 11/18/2010 | US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses |
| 11/18/2010 | US20100292207 Substituted indazole derivatives active as kinase inhibitors |
| 11/18/2010 | US20100292204 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists |
| 11/18/2010 | US20100292195 Low burst polymers and methods to produce polymer |
| 11/18/2010 | US20100291228 Scavenger of in vivo harmful reactive oxygen species and/or free radicals |
| 11/18/2010 | US20100291226 Pharmaceutical Formulations Based on Apolar and Polar Lipids for Ophthalmic Use |
| 11/18/2010 | US20100291182 Drug-Loaded Fibers |
| 11/18/2010 | US20100291138 Vaccine |
| 11/18/2010 | US20100291106 Compositions and methods for antibodies targeting complement protein c3b |
| 11/18/2010 | US20100291097 Monoclonal antibody |
| 11/18/2010 | US20100291026 Piperidine inhibitors of janus kinase 3 |
| 11/18/2010 | US20100291019 Methods of Using Ophthalmic Compositions Comprising Povidone-Iodine |
| 11/18/2010 | US20100288665 Therapeutic formulations for the treatment of cold and flu-like symptoms |
| 11/18/2010 | DE102009022046A1 Entfärbte Extrakte der Pflanze Pandanus conoideus Discolored extracts of the plant Pandanus conoideus |
| 11/18/2010 | DE102009021372A1 Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 11/18/2010 | CA2761740A1 Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 11/17/2010 | EP2251028A1 Treatment of eye diseases using encapsulated cells encoding and secreting an anti-angiogenic factor and/or a neuroprotective factor |
| 11/17/2010 | EP2251009A1 Prophylactic or therapeutic agent for ocular disease accompanied by optic nerve disorder |
| 11/17/2010 | EP2249863A1 Method of improving wound healing |
| 11/17/2010 | EP2249836A1 Fluoroquinolone derivatives for ophthalmic applications |
| 11/17/2010 | EP2249829A1 Tetrahydropyridoethers for treatment of amd |
| 11/17/2010 | EP2249800A2 Magnetic cells for localizing delivery and tissue repair |
| 11/17/2010 | EP1585522B1 Quinazolinones as potassium channel modulators |
| 11/17/2010 | CN101888878A Novel antibodies |
| 11/17/2010 | CN101888839A Compositions and methods for the treatment of ophthalmic conditions |
| 11/17/2010 | CN101884767A Plant extract composite for preventing diabetes complication and senium and preparation method thereof |
| 11/17/2010 | CN101884766A Healthcare product or medicine for preventing diabetes complication and senium and preparation method thereof |
| 11/17/2010 | CN101884765A Medicament for treating big belly known as beer belly |
| 11/17/2010 | CN101884715A Medicament for treating optic neuritis and preparation method thereof |
| 11/17/2010 | CN101884695A Traditional Chinese medicine for treating conjunctivitis and keratitis |
| 11/17/2010 | CN101884693A Traditional Chinese medicine for treating diabetic eye diseases |
| 11/17/2010 | CN101884649A Traditional Chinese medicine for treating oculopathy |
| 11/17/2010 | CN101214246B Palmatine nano particle preparations and preparation method thereof |
| 11/17/2010 | CN101199744B Oral administration Chinese medicine for treating tinnitus |
| 11/17/2010 | CN101077188B Medicinal diet for strengthening brain and improving eyesight students nutrition food |
| 11/17/2010 | CN101073666B Method for producing kallidin proenzyme raw-material medicine |
| 11/16/2010 | US7833993 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 11/16/2010 | US7833977 Use of L-carnitine for the treatment of cataract of non diabetic origin due to altered chaperone proteins by stabilizing the protein activity |
| 11/16/2010 | CA2479084C Vdac regulator |
| 11/16/2010 | CA2471220C Novel alkansulfonamides as endothelin antagonists |
| 11/16/2010 | CA2452114C Tgf-.beta. superfamily production/secretion promoter |
| 11/16/2010 | CA2436846C Thioether substituted imidazoquinolines |
| 11/16/2010 | CA2398901C Methods and compositions for treating conditions of the eye |
| 11/16/2010 | CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition |
| 11/11/2010 | WO2010129553A1 S1p3 receptor inhibitors for treating conditions of the eye |
| 11/11/2010 | WO2010129145A2 Methods and compositions for treating dry eye |
| 11/11/2010 | WO2010128486A2 Ophthalmic formulation for the treatment and prevention of pterygium |
| 11/11/2010 | WO2010128053A1 Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases |
| 11/11/2010 | WO2010099436A9 Peptidomimetic cyclic compounds for treating retinitis pigmentosa |
| 11/11/2010 | WO2010042886A3 Pyrones for the treatment of metabolic disorders |
| 11/11/2010 | WO2009135581A9 Nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 11/11/2010 | US20100286253 Method for treating ocular neovascularization |
| 11/11/2010 | US20100286247 Methods of Protection from Oxidative Stress |
| 11/11/2010 | US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 11/11/2010 | US20100286230 Modulation of trpv expression levels |
| 11/11/2010 | US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 11/11/2010 | US20100286197 Carboxamide Derivatives As Therapeutic Agents |
| 11/11/2010 | US20100286190 Certain substituted ureas, as modulators of kinase activity |
| 11/11/2010 | US20100286146 Carboxamide compounds and their use as calpain inhibitors |
| 11/11/2010 | US20100286136 Dihydronaphthyridinyl and related compounds for use in treating ophthalmological disorders |
| 11/11/2010 | US20100286129 Novel benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 11/11/2010 | US20100286121 Water-Immiscible Materials as Vehicles for Drug Delivery |
| 11/11/2010 | US20100286078 Topical ophthalmic compositions containing tobramycin and dexamethasone |
| 11/11/2010 | US20100286065 Topical methods and compositions for the treatment of eye diseases and conditions |
| 11/11/2010 | US20100286054 Composition |